Infectious Diseases News and Research

RSS

New vaccine candidate shows great promise at fighting respiratory syncytial virus

Johns Hopkins Bloomberg School of Public Health researchers say a new candidate vaccine against respiratory syncytial virus (RSV) made with a weakened version of the virus shows great promise at fighting the disease, the leading cause of hospitalization for children under the age of one in the U.S.

5 Nov 2015

ESCMID, ESWI call for increased flu vaccination coverage amongst healthcare professionals

The European Society of Clinical Microbiology and Infectious Disease (ESCMID) – an organization that explores risk assessment, knowledge sharing and best practices in the fight against infectious disease – is calling on the healthcare industry to lead by example and implement universal flu vaccination for healthcare workers.

5 Nov 2015

JEDI T-cells provide unique technology to study, visualize immune responses and immunotherapies

When it comes to fending off disease and helping prevent people from falling ill, the body's immune system -- armed with T-cells that help eliminate cancer cells, virus-infected cells and more -- is second to none. But exactly how the immune system works remains, in many ways, a mystery, as there are numerous cell types whose functions and interactions with our immune systems have not been well understood.

5 Nov 2015

Researchers track re-emergence of scarlet fever-causing bacteria

An international study led by University of Queensland researchers has tracked the re-emergence of a childhood disease which had largely disappeared over the past 100 years.

4 Nov 2015

Johnson & Johnson signs definitive agreement to purchase Novira Therapeutics

Johnson & Johnson today announced a definitive agreement to acquire Novira Therapeutics, Inc., a privately held, clinical-stage biopharmaceutical company developing novel therapies for curative treatment of chronic hepatitis B virus (HBV) infection.

4 Nov 2015

BD reports quarterly adjusted revenues of $3.067 billion for fourth fiscal quarter 2015

BD (Becton, Dickinson and Company), a leading global medical technology company, today reported quarterly adjusted revenues of $3.067 billion for the fourth fiscal quarter ended September 30, 2015, an increase of 39.3 percent over the prior-year period as reported, or 49.1 percent on a currency-neutral basis.

4 Nov 2015

Millions more bird species killed by West Nile virus than previously thought

West Nile virus is killing millions more birds and affecting many more bird species than previously thought, according to new research from a multi-university team of researchers.

4 Nov 2015

New study finds how African immigrants stigmatized during recent Ebola crisis

The deadly Ebola virus outbreak in West Africa also took its toll socially on one of the fastest growing populations in the United States, African immigrants. Guy-Lucien Whembolua, a University of Cincinnati assistant professor of Africana studies, leads an analysis of national news coverage of the Ebola scare in a poster presentation on Nov. 2, at the 143rd American Public Health Association Annual Meeting and Expo, in Chicago.

4 Nov 2015

Study provides novel insight into the evolution of hepatitis A virus and how it spreads to humans

Researchers at the University of North Carolina at Chapel Hill are part of an international team led by the University of Bonn, Germany, who have found a link between the origin of hepatitis A virus (HAV) and small mammals.

4 Nov 2015

Approval to start trial of Videregen's replacement trachea technology

The INSPIRE consortium, led by Videregen Ltd, has received approval from the MHRA1 to start a UK clinical trial with its tissue engineered replacement trachea.

3 Nov 2015

Alnylam presents positive ongoing phase 2 open-label extension data for Patisiran and Revusiran

Alnylam Pharmaceuticals, Inc. has announced new results from its ongoing Phase 2 open-label extension (OLE) studies with patisiran and revusiran, investigational RNAi therapeutics targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis (ATTR amyloidosis).

3 Nov 2015

Deaths from avoidable risk factors: an interview with Dr Ali Mokdad, IHME

The study showed that about thirty percent to maybe half of the leading causes of death in the world are preventable. These are risk factors that you could manage and thus you could prevent a lot of premature deaths.

3 Nov 2015

Study identifies potential new approaches to curing parasitic diseases

A study in the Proceedings of the National Academy of Sciences shows that some forms of the single celled parasites, Trypanosoma brucei and Toxoplasma gondii behave like cancer cells.

3 Nov 2015

Microbiome researcher Martin J. Blaser earns GUMC's Cura Personalis Award

Georgetown University Medical Center will bestow its highest honor, the Cura Personalis Award, upon Martin J. Blaser, MD, a world-renowned microbiome researcher and clinician.

3 Nov 2015

CureVac raises €100M to enable rapid expansion of mRNA development platform, clinical-stage pipeline

CureVac, a clinical-stage biopharmaceutical company pioneering the field of mRNA-based technology, today announces that it has raised about $110 million (€100 million) to enable accelerated expansion of its industry-leading messenger RNA (mRNA) development platform and clinical-stage pipeline.

3 Nov 2015

Salk scientists uncover enzyme responsible for suppressing deadly lung cancer

Scientists at the Salk Institute have uncovered a molecule whose mutation leads to the aggressive growth of a common and deadly type of lung cancer in humans.

3 Nov 2015

Self-disseminating vaccines could prevent EID transmission from animals to humans

The 2014/2015 Ebola outbreak in West Africa shone the spotlight not only on the unpreparedness of local health services and science to deal with the pandemic, but also on the phenomenon of emerging infectious diseases (EIDs).

2 Nov 2015

Loughborough University's lab-in-a-briefcase may boost cancer detection rates in developing countries

Academics at Loughborough University hope to boost early detection rates of cancer in developing countries with their portable lab-in-a-briefcase that can operate even at high temperatures.

31 Oct 2015

Saint Louis University ophthalmologist offers tips to manage night vision issues

Owls and cats are at an advantage as the days get darker, but humans may notice their vision takes a hit during their evening commute home as daylight hours shrink.

31 Oct 2015

New campaign raises awareness of City of Hope's life-saving mission and impact

Imagine being diagnosed with one of the most rare and aggressive forms of breast cancer, given a five percent chance to live and told having children will never be an option. Southern California local Kommah McDowell was told just that— and then she went to City of Hope.

31 Oct 2015

Infectious Diseases News and Research

New vaccine candidate shows great promise at fighting respiratory syncytial virus

ESCMID, ESWI call for increased flu vaccination coverage amongst healthcare professionals

JEDI T-cells provide unique technology to study, visualize immune responses and immunotherapies

Researchers track re-emergence of scarlet fever-causing bacteria

Johnson & Johnson signs definitive agreement to purchase Novira Therapeutics

BD reports quarterly adjusted revenues of $3.067 billion for fourth fiscal quarter 2015

Millions more bird species killed by West Nile virus than previously thought

New study finds how African immigrants stigmatized during recent Ebola crisis

Study provides novel insight into the evolution of hepatitis A virus and how it spreads to humans

Approval to start trial of Videregen's replacement trachea technology

Alnylam presents positive ongoing phase 2 open-label extension data for Patisiran and Revusiran

Deaths from avoidable risk factors: an interview with Dr Ali Mokdad, IHME

Study identifies potential new approaches to curing parasitic diseases

Microbiome researcher Martin J. Blaser earns GUMC's Cura Personalis Award

CureVac raises €100M to enable rapid expansion of mRNA development platform, clinical-stage pipeline

Salk scientists uncover enzyme responsible for suppressing deadly lung cancer

Self-disseminating vaccines could prevent EID transmission from animals to humans

Loughborough University's lab-in-a-briefcase may boost cancer detection rates in developing countries

Saint Louis University ophthalmologist offers tips to manage night vision issues

New campaign raises awareness of City of Hope's life-saving mission and impact

eBook: Advancing infectious disease vaccine development eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News